Medical big data holds immense potential for enhancing healthcare quality and advancing medical research. However, cross-center sharing of medical data, essential for constructing large and diverse ...

Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be ...

Leesburg, VA, May 17, 2023—According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), deep learning–based computer-aided diagnosis (CAD) for breast lesion ...

A multicenter American College of Radiology Imaging Network trial has determined that breast lesions categorized as BI-RADS 3 or probably benign have low malignancy rates, suggesting that follow-up ...

LOS ANGELES — The Thyroid Imaging Reporting and Data System (TI-RADS), modeled on the BI-RADS classification of breast lesions, has the highest diagnostic accuracy for stratifying thyroid nodules, ...

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), deep learning–based computer-aided diagnosis (CAD) for breast lesion classification on ultrasound ...

Contrast-enhanced ultrasound (CEUS) has emerged as a vital imaging tool in the detection, characterisation and prognostic evaluation of breast cancer. By utilising microbubble contrast agents to ...

Receiving your mammogram results can be an emotional experience. Whether the news is positive or requires further investigation, it’s important to understand what these results mean for your breast ...

Breast cancer is the most common cancer in the UK, representing around one‑third of all new cancers diagnosed in women (Office for National Statistics 2012). Around 55,000 people are diagnosed with ...

March 2, 2012 (Vienna, Austria) — Multimodal tomography (MUT), a novel 3-dimensional (3D) imaging technology, is effective in detecting and classifying breast lesions as small as 2 mm in size, ...

Researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be re-evaluated with imaging in 12 months, reducing patient anxiety, follow-up exams and ...